Literature DB >> 7228873

RNA polymerase from Clostridium acidi-urici. Characterization of a naturally occurring rifampicin-resistant bacterial enzyme.

C L Murray, J C Rabinowitz.   

Abstract

We report here the isolation of a prokaryotic RNA polymerase that shows pronounced template specificity. The enzyme from Clostridium acidi-urici is highly active on DNA templates isolated from phage that infect Gram-positive organisms and is essentially inactive at either high or low ionic strength on DNA from phage associated with Gram-negative bacteria. The enzyme is also unique among RNA polymerases isolated from wild type bacteria in being highly resistant to inhibition by rifampicin. These properties are characteristic of the enzyme present in several independently isolated strains of C. acidi-urici. However, RNA polymerase present in other clostridial species resembles the enzyme present in Bacillus subtilis in sensitivity to rifampicin and template specificity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7228873

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  4 in total

1.  Escherichia coli and Pseudomonas putida RNA polymerases display identical contacts with promoters.

Authors:  A I Gragerov; A A Chenchik; V A Aivasashvilli; R Sh Beabealashvilli; V G Nikiforov
Journal:  Mol Gen Genet       Date:  1984

2.  Transcriptional analyses of the Bacillus licheniformis penP gene.

Authors:  J R McLaughlin; S Y Chang; S Chang
Journal:  Nucleic Acids Res       Date:  1982-07-10       Impact factor: 16.971

3.  Cloning and nucleotide sequence determination of the Clostridium pasteurianum ferredoxin gene.

Authors:  M C Graves; G T Mullenbach; J C Rabinowitz
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

4.  Nucleotide sequences of two Bacillus subtilis promoters used by Bacillus subtilis sigma-28 RNA polymerase.

Authors:  M Z Gilman; J L Wiggs; M J Chamberlin
Journal:  Nucleic Acids Res       Date:  1981-11-25       Impact factor: 16.971

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.